All Type of News
New product licenses total 196 in first half
Licenses for new products in the first half of this year totaled 196, compared with 497 from a year earlier, showing setback due to implementation of validation system on prescription drugs, which took effect last yea...
Leading drugmakers refuse to give in to request for de-facto bribe
Two leading pharmaceutical companies have recently pledged to stop the practice of giving “illegal rebates'' here.
Chairmen of the two pharmaceutical firms said the rebates must be stopped not only because they wer...
cGMP system is on right track, KFDA says
The current good manufacturing practice (cGMP) system, which was introduced in July last year, has been put on the right track, according to the Korea Food and Drug Administration.
The health watchdog said a total ...
Dong-A reports Q2 earnings
Dong-A Pharm, Korea's largest pharmaceutical company, reported better than expected second-quarter earnings on July 24, buoyed by brisk sales of prescription drugs and strong gains of Zydena in overseas markets.
Th...
Choong-wae to develop new anticancer drug targeting Wnt signaling pathway
Choong-wae Pharm unveiled its plan to develop a new antitumor medicine (code name: CWP231A) targeting Wnt signaling pathway.
Wnt signaling plays an important role in regulating cell proliferation and differentiatio...
Medical specialists calls for hepatitis A vaccination
Korea should work out preventive measures over hepatitis A as the number of those infected reached about 9,600 in just one year, according to the Korean Association for the Study of the Liver.
The association recom...
7 of 10 doctors open ENT clinics
68.6 percent of 78,518 medical doctors have newly opened ENT (ear, nose and throat) clinics, as they have the most patients. An ENT sees over 101 patients a day, while an orthopedist and a pediatrician see a respectiv...
Uwangchungsimwon containing L-muscone can be marketed without validation
Oriental medicines, such as Uwangchungsimwon, can be sold without validation irrespective of natural or synthetic muscone, according to the Korea Food and Drug Administration.
The drug agency said that any herbal i...
MSD Korea releases Cozaar XQ
MSD Korea says it has recently released Cozaar XQ, an antihypertensive drug which combines losartan potassium and amlodipine camsylate.
The safety and efficacy of Cozaar XQ was already demonstrated in a variety of ...
Homegrown flu vaccine gets green light
Green Cross Corp. said on July 22 that it received a marketing authorization for its independently developed influenza vaccine “GC Flu” injection by the Korea Food and Drug Administration.
The company said the mark...
